Cargando…
Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
Donepezil is one of the cholinesterase inhibitors that are indicated for the treatment of mild to moderate Alzheimer's disease (AD). Pharmacokinetic analysis has shown that donepezil is primarily eliminated by renal excretion rather than biliary excretion in humans. Therefore, patients with imp...
Autores principales: | Yiannopoulou, Konstantina G., Anastasiou, Aikaterini I., Kyrozis, Andreas, Anastasiou, Ioannis P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787415/ https://www.ncbi.nlm.nih.gov/pubmed/31616673 http://dx.doi.org/10.1159/000502682 |
Ejemplares similares
-
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
por: Yiannopoulou, Konstantina G., et al.
Publicado: (2019) -
Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review
por: Yiannopoulou, Konstantina, et al.
Publicado: (2023) -
Early Onset Dementia in Ataxia Associated with Ocular Apraxia Type 1 (AOA1)
por: Aikaterini, Anastasiou I., et al.
Publicado: (2020) -
Current and Future Treatments in Alzheimer Disease: An Update
por: Yiannopoulou, Konstantina G, et al.
Publicado: (2020) -
Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)